Podcast Episodes
Back to Search
Episode 109: Adjuvant pembrolizumab in renal cancer
Season 1 Episode 112
Toni Choueiri describes the KN564 study in detail.
5 years, 4 months ago
Episode 108: Peter O'Donnell gives five year follow-up data on front line pembrolizumab in urothelial cancer
Season 1 Episode 108
Tom and Peter continue to see things differently - has the data changed things?
5 years, 4 months ago
Episode 107: ASCO 2021: Neoadjuvant chemo/nivolumab as bladder sparing
Season 1 Episode 107
Matt Galsky describes his Phase 2 study and gives a vision of the future.
5 years, 4 months ago
Episode 106: Summary of the three bladder sparing neoadjuvant trials at ASCO 2021
Season 1 Episode 108
Andrea Necchi gives a summary of the three abstracts.
5 years, 4 months ago
Episode 105: A Phase 2 study of novel immune combinations (ICOS) in bladder cancer
Season 1 Episode 107
Arjun Balar discusses this and his neoadjuvant chemo/immune/RT trial.
5 years, 4 months ago
Episode 104: Plenary Session 177lu-PSMA-617 in Prostate Cancer
Season 1 Episode 104
Mike Morris does his stuff.
5 years, 4 months ago
Episode 103: Targeting the microbiome to increase the activity of immune therapy in renal cancer
Season 1 Episode 103
Monty Pal describes a small randomised trial of ipi/nivo plus CMB588.
5 years, 4 months ago
Episode 102: Adjuvant therapy in melanoma - how it will help inform the renal community
Season 1 Episode 104
James Larkin describes learning from adjuvant immune checkpoint inhibitors in melanoma.
5 years, 5 months ago
Episode 101: The Uromigos Paper of the Month - Belzutifan in renal cancer
Season 1 Episode 101
Eric Jonasch gives an overview of the recent Nature Medicine publication.
5 years, 5 months ago
Episode 100: The Uromigos 100th Podcast - Looking to the Future
Season 1 Episode 100
Chris Sweeney, Kala Sridhar and David McDermott discuss the future.
5 years, 5 months ago